^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
LiquidMARK™ Bile Duct test

Company:
Lucence
Type:
Laboratory Developed Test
Related tests:
Evidence

News

10ms
Lucence and Innovent announce strategic collaboration on bile duct cancer (Lucence Press Release)
"Lucence...announced...a strategic collaboration with Innovent Biologics, Inc. to improve access of Hong Kong patients with advanced bile duct cancer (cholangiocarcinoma) to the FDA-approved targeted treatment Pemazyre® (pemigatinib)...Under the agreement, Innovent will sponsor Lucence’s LiquidMARK™ Bile Duct test for Hong Kong patients with a diagnosis of bile duct cancer who fulfil criteria."
Licensing / partnership
|
LiquidMARK™ Bile Duct test